← Eichor
Condition: Barretts Esophagus With Dysplasia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Barretts Esophagus With Dysplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796
Australian Barrett's Cohort With Dysplasia and Early Cancer Study
Phase N/A · 1 location(s) · Professor Michael Bourke · NCT02198976
EMR Versus ESD for Barrett's Neoplasia
NA · 6 location(s) · St. Antonius Hospital · NCT05276791
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
NA · 5 location(s) · Mayo Clinic · NCT06071845
Clinical Utility of WATS3D: A 5-Year Prospective Study
Phase N/A · 1 location(s) · CDx Diagnostics · NCT04312633
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Survei
NA · 14 location(s) · University of Colorado, Denver · NCT05530343
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
NA · 23 location(s) · University of Colorado, Denver · NCT05753748
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Phase 2 · 1 location(s) · University Medical Center Groningen · NCT05745857
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.